帕金森病特异性焦虑量表（PDSAI）的编制与验证
Development and Validation of the Parkinson's Disease Specific Anxiety Inventory (PDSAI).
作者信息
Dissanayaka Nadeeka N, Pourzinal Dana, Byrne Gerard, Pachana Nancy A, O'Sullivan John D, White Elizabeth, Au Tiffany, Yang Jihyun, Interian Alejandro, Rodriguez Kailyn, Dobkin Roseanne D
机构信息
UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.
School of Psychology, The University of Queensland, Brisbane, QLD, Australia.
出版信息
J Geriatr Psychiatry Neurol. 2025 Apr 8;38(5):8919887251332660. doi: 10.1177/08919887251332660.
BackgroundAnxiety is poorly recognized and inadequately treated in persons with Parkinson's disease (PD).ObjectiveThe present study aimed to develop and validate a new clinical screening and research outcome measure to identify triggers and manifestations of anxiety specific to PD, the Parkinson's disease Specific Anxiety Inventory (PDSAI).MethodData from PDSAI derived from 172 people with PD across Australia and the United States was used to assess the reliability and validity of the inventory. Construct validity was assessed.ResultsFrequency analyses revealed low rates of missing data across the 40 items. The inventory demonstrated high reliability (Cronbach's a = 0.93, split-half = 0.68) and mid to high concurrent validity between the PDSAI and (i) Hamilton Anxiety Scale (r = 0.51), (ii) Liebowitz Social Anxiety Scale (r = 0.697) and Parkinson's Anxiety Scale (r = 0.747).ConclusionsThe PDSAI is a valid and reliable tool designed to capture PD specific triggers and manifestations of anxiety in people with PD.
背景
帕金森病（PD）患者的焦虑往往未得到充分认识和治疗。
目的
本研究旨在开发并验证一种新的临床筛查和研究结果测量工具，以识别帕金森病特有的焦虑触发因素和表现，即帕金森病特异性焦虑量表（PDSAI）。
方法
来自澳大利亚和美国的172名帕金森病患者的PDSAI数据用于评估该量表的信度和效度。评估了结构效度。
结果
频率分析显示，40个项目中缺失数据的发生率较低。该量表显示出高信度（克朗巴哈α系数=0.93，分半系数=0.68），且PDSAI与（i）汉密尔顿焦虑量表（r=0.51）、（ii）利博维茨社交焦虑量表（r=0.697）和帕金森焦虑量表（r=0.747）之间具有中到高的同时效度。
结论
PDSAI是一种有效且可靠的工具，旨在捕捉帕金森病患者特有的焦虑触发因素和表现。
Zotero 插件